How gut and lung bacteria differ in COPD patients
Part of Lungs & breathing clinical trials.
This study looks at bacteria and other substances in the body of people with COPD compared to healthy smokers, to find clues about how COPD affects health. It may help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have COPD (confirmed by a breathing test showing FEV1/FVC less than 0.7)
- You have not had a flare-up (sudden worsening of symptoms) in the last 3 months
- You have not used antibiotics in the last 3 months
- You are able to provide stool, sputum (phlegm), and blood samples
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the germs in exhaled (breathed-out) air to compare people with COPD to people without COPD. It may help researchers better understand lung differences and what could drive COPD.
This study looks at how the body’s “innate” (first-line) immune system works in people with COPD compared with healthy volunteers. It may help researchers understand COPD inflammation and how immune responses could be targeted in the future.
This study follows people who currently smoke and people who may have newly found COPD (chronic obstructive lung disease) based on breathing test results. It aims to better understand lung disease in real life and what it means for health over time.
This study looks at the bacteria in your airways, how infections affect you, and chest imaging (like CT scans) in people with chronic airway inflammation (COPD, asthma, bronchiectasis). It may help find better ways to treat these conditions.
This study looks at the lung’s tiny bacteria (microbiome) and inflammation in people with early COPD who have a smoking history. It compares them with smokers who have normal breathing tests, to better understand what may drive COPD early on.
This study looks at different forms of COPD to find better ways to treat them. It may help you understand your own condition and receive more personalized care.
Hear when a new Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.